Wells Fargo’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $463M | Sell |
|
|||||
2025
Q1 | $573M | Buy |
|
|||||
2024
Q4 | $590M | Buy |
|
|||||
2024
Q3 | $607M | Sell |
|
|||||
2024
Q2 | $595M | Buy |
|
|||||
2024
Q1 | $563M | Buy |
|
|||||
2023
Q4 | $544M | Sell |
|
|||||
2023
Q3 | $718M | Sell |
|
|||||
2023
Q2 | $837M | Buy |
|
|||||
2023
Q1 | $925M | Buy |
|
|||||
2022
Q4 | $1.16B | Buy |
|
|||||
2022
Q3 | $980M | Sell |
|
|||||
2022
Q2 | $1.2B | Sell |
|
|||||
2022
Q1 | $1.3B | Buy |
|
|||||
2021
Q4 | $1.36B | Sell |
|
|||||
2021
Q3 | $1.19B | Sell |
|
|||||
2021
Q2 | $1.17B | Buy |
|
|||||
2021
Q1 | $1.06B | Buy |
|
|||||
2020
Q4 | $1.05B | Sell |
|
|||||
2020
Q3 | $1.08B | Buy |
|
|||||
2020
Q2 | $932M | Buy |
|
|||||
2020
Q1 | $907M | Buy |
|
|||||
2019
Q4 | $1.05B | Buy |
|
|||||
2019
Q3 | $960M | Sell |
|
|||||
2019
Q2 | $1.58B | Sell |
|
|||||
2019
Q1 | $1.57B | Sell |
|
|||||
2018
Q4 | $1.74B | Buy |
|
|||||
2018
Q3 | $1.76B | Sell |
|
|||||
2018
Q2 | $1.5B | Sell |
|
|||||
2018
Q1 | $1.48B | Sell |
|
|||||
2017
Q4 | $1.54B | Buy |
|
|||||
2017
Q3 | $1.27B | Sell |
|
|||||
2017
Q2 | $1.31B | Buy |
|
|||||
2017
Q1 | $1.27B | Buy |
|
|||||
2016
Q4 | $1.1B | Buy |
|
|||||
2016
Q3 | $1.08B | Buy |
|
|||||
2016
Q2 | $1.01B | Buy |
|
|||||
2016
Q1 | $813M | Sell |
|
|||||
2015
Q4 | $939M | Buy |
|
|||||
2015
Q3 | $881M | Buy |
|
|||||
2015
Q2 | $847M | Buy |
|
|||||
2015
Q1 | $874M | Sell |
|
|||||
2014
Q4 | $857M | Buy |
|
|||||
2014
Q3 | $698M | Buy |
|
|||||
2014
Q2 | $691M | Buy |
|
|||||
2014
Q1 | $742M | Buy |
|
|||||
2013
Q4 | $688M | Buy |
|
|||||
2013
Q3 | $630M | Buy |
|
|||||
2013
Q2 | $600M | Buy |
|